New triazoles and echinocandins: mode of action,in vitroactivity and mechanisms of resistance

In Vitro Activities of Fluconazole and Voriconazole against Clinical Isolates of Candida spp. Determined by Disk Diffusion Testing in Turin, Italy

(2009) N. Mandras et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of Isavuconazole against Aspergillus Species and Zygomycetes According to the Methodology of the European Committee on Antimicrobial Susceptibility Testing

(2009) S. Perkhofer et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of Posaconazole and Other Antifungal Agents against Mucorales Strains Identified by Sequencing of Internal Transcribed Spacers

(2009) A. Alastruey-Izquierdo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit

(2009) M.A. Ghannoum et al.   CLINICAL MICROBIOLOGY AND INFECTION

Efflux-Mediated Antifungal Drug Resistance

(2009) R. D. Cannon et al.   CLINICAL MICROBIOLOGY REVIEWS

In vitro activity of caspofungin and voriconazole against uncommon Candida spp.

(2009) Adela Enache-Angoulvant et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Susceptibility profile of clinical isolates of non-Cryptococcus neoformans/non-Cryptococcus gattii Cyptococcus species and literature review

(2009) Leticia Bernal-Martinez et al.   MEDICAL MYCOLOGY

Mutations in the fks1 Gene in Candida albicans, C. tropicalis, and C. krusei Correlate with Elevated Caspofungin MICs Uncovered in AM3 Medium Using the Method of the European Committee on Antibiotic Susceptibility Testing

(2008) M. Desnos-Ollivier et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Reduced Candida glabrata Susceptibility Secondary to an FKS1 Mutation Developed during Candidemia Treatment

(2008) J. D. Cleary et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Susceptibilities of Invasive Isolates of Candida Species: Rapid Increase in Rates of Fluconazole Susceptible-Dose Dependent Candida glabrata Isolates

(2008) S.-Y. Ruan et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Species Distribution and In Vitro Antifungal Susceptibility Patterns of 75 Clinical Isolates of Fusarium spp. from Northern Italy

(2008) A. M. Tortorano et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans

(2008) G. R. Thompson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activities of Various Antifungal Drugs against Aspergillus terreus: Global Assessment Using the Methodology of the European Committee on Antimicrobial Susceptibility Testing

(2008) C. Lass-Florl et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Susceptibility Testing and Molecular Classification of Paecilomyces spp.

(2008) M. V. Castelli et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Isolates of Aspergillus Species Remain Fully Susceptible to Voriconazole in the Post-Voriconazole Era

(2008) J. Guinea et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Establishing In Vitro-In Vivo Correlations for Aspergillus fumigatus: the Challenge of Azoles versus Echinocandins

(2008) M. C. Arendrup et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Activity of the New Azole Isavuconazole (BAL4815) Compared with Six Other Antifungal Agents against 162 Cryptococcus neoformans Isolates from Cuba

(2008) M.-T. Illnait-Zaragozi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vitro Antifungal Activities of Isavuconazole (BAL4815), Voriconazole, and Fluconazole against 1,007 Isolates of Zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium Species

(2008) J. Guinea et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

(2008) Thomas J. Walsh et al.   CLINICAL INFECTIOUS DISEASES

Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods

(2008) Naureen J. Iqbal et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Comparison of posaconazole and voriconazole in vitro killing against Candida krusei

(2008) Emilia Cantón et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.

(2008) Daniel J. Diekema et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

In vitro activity of amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin and terbinafine against Scytalidium dimidiatum and Scytalidium hyalinum clinical isolates

(2008) C. Lacroix et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods

(2008) A. Alastruey-Izquierdo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

(2008) M. A. Pfaller et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Comparativein vitroactivities of posaconazole, voriconazole, itraconazole, and amphotericin B againstAspergillusandRhizopus, and synergy testing forRhizopus

(2008) Sevtap Arikan et al.   MEDICAL MYCOLOGY

In vitroactivities of isavuconazole against opportunistic filamentous and dimorphic fungi

(2008) Gloria M. González   MEDICAL MYCOLOGY

Current Options in Antifungal Pharmacotherapy

(2008) John Mohr et al.   PHARMACOTHERAPY

Update on Azole Antifungals

(2008) Dimitrios Zonios et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE

Resistance to Antifungal Agents: Mechanisms and Clinical Impact

(2007) Z. A. Kanafani et al.   CLINICAL INFECTIOUS DISEASES

New and emerging treatments for fungal infections

(2007) A. C. Pasqualotto et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY